drugset / Trial / NCT05874336
An Open-Label, Two-Part Study Designed to Assess the Absolute Bioavailability and Mass Balance of Aramchol
NaSingle-groupOpen-labelTreatment
Summary
A two-part open-label study to assess the absolute bioavailability of aramchol and the mass balance recovery, metabolite profile and identification of metabolite structures for \[14C\]-aramchol in healthy male subjects
Timeline
- Start
- 2020-06-17
- Primary completion
- 2020-08-11
- Completion
- 2020-08-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aramchol | Other / unclassified | — | — |